DavidRobertShprecherDO

Neurology • Sun City, AZ

Movement Disorder

Movement Disorders Director at Banner Health

Join to view full profile

Dr. Shprecher is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shprecher's full profile

Already have an account?

Office
10515 W Santa Fe Dr
Bldg B
Sun City, AZ 85351
Phone+1 623-832-6530

Fax+1 623-832-6504

Summary

I direct the Movement Disorders Program at the Cleo Roberts Center, Banner Sun Health Research Institute in Sun City, AZ. My training, clinical evaluation/ management and clinical research are focused on movement disorders including Parkinson disease, tics and Tourette syndrome, dystonia, essential tremor, Huntington disease, multiple system atrophy, progressive supranuclear palsy, and tardive dyskinesia.

Education & Training

University of RochesterM.S, Clinical Investigation, 2007 - 2011
University of RochesterM.S., Clinical Investigation, 2007 - 2011
U Rochester/Strong Mem2007 - 2009
University of Utah HealthResidency, Neurology, 2004 - 2007
University of Utah HealthInternship, Internal Medicine, 2003 - 2004
Lake Erie College of Osteopathic Medicine - Seton HillClass of 2003
Cornell University College of Arts and SciencesBS, Biology, 1991 - 1995
Cornell UniversityB.S., Biology, 1991 - 1995

Certifications & Licensure

UT State License 2004 - 2026
AZ State License 2015 - 2025
NY State License 2007 - 2010
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

Utah Affiliate Service Award Huntington Disease Society of America, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
NIH Clinical Research Loan Repayment Program 2008, 2010
NIH Training Grant T32 NS 07338-11 2007, 2009
Neurology Resident Teaching Award University of Utah, 2007
Psi Sigma Alpha Lake Erie College of Osteopathic Medicine, 2003
Principal Investigator
Join now to see all

Clinical Trials

MRI Study of Tic Remission in Tourette Syndrome Start of enrollment: 2010 Jan 01
Completed
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort Start of enrollment: 2012 Jul 01
Recruiting
Efficacy of Isradipine in Early Parkinson Disease Start of enrollment: 2014 Nov 01
Completed
Phase 3
Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome Start of enrollment: 2014 Sep 01
Completed
Phase 1
Study of Urate Elevation in Parkinson's Disease, Phase 3 Start of enrollment: 2016 Jun 01
Completed
Phase 3
A Pilot Study Of SD-809 (Deutetrabenazine) In Moderate To Severe Tourette Syndrome (TS) Start of enrollment: 2014 Jul 01
Completed
Phase 1
Safety and Efficacy Study of NBI-98854 in Children and Adolescents With Tourette Syndrome Start of enrollment: 2016 Mar 23
Completed
Phase 2
Study of BIIB092 in Participants With Progressive Supranuclear Palsy Start of enrollment: 2017 Jun 01
Terminated
Phase 2
The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study Start of enrollment: 2017 Mar 30
Terminated
A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB) Start of enrollment: 2017 Nov 09
Completed
Phase 2
Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease Start of enrollment: 2018 Jan 10
Terminated
Phase 2
A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment Start of enrollment: 2018 Apr 18
Completed
Phase 1
Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents Start of enrollment: 2018 Feb 05
Completed
Phase 2, Phase 3
Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome Start of enrollment: 2018 Apr 17
Terminated
Phase 2
Rollover Study for Continuing NBI-98854 Administration in Pediatric Subjects With Tourette Syndrome Start of enrollment: 2018 Oct 17
Terminated
Phase 2
A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD) Start of enrollment: 2019 Apr 29
Completed
Phase 3
Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET) Start of enrollment: 2018 Dec 10
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

81 citations
The syndrome of delayed post-hypoxic leukoencephalopathy.
David Shprecher, Lahar Mehta
Neurorehabilitation. 2010-01-01
20 citations
Baseline characteristics of the North American prodromal Synucleinopathy cohort.
Jonathan E Elliott, Miranda M Lim, Allison T Keil, Ronald B Postuma, Amelie Pelletier
Annals of Clinical and Translational Neurology. 2023-04-01
106 citations
Randomized controlled trial of deutetrabenazine for tardive dyskinesia the ARM-TD study
Hubert H. Fernandez, Stewart A. Factor, Robert A. Hauser, Joohi Jimenez-Shahed, William G. Ondo
Neurology. 2017-05-23

Journal Articles

Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial
Writing Group for the NINDS Exploratory Trials in Parkinson Disease (NET-PD)Investigators, Kieburtz K, Tilley BC, Elm JJ, et al, JAMA, 1/10/2015
The RAB39B pG192R mutation causes X-linked dominant Parkinson's disease
Mata IF, Jang Y, Kim CH, Hanna DS, Dorschner MO, Samii A, Agarwal P, Roberts JW, Klepitskaya O, Shprecher DR, Chung KA, Factor SA, Espay AJ, Revilla FJ, Higgins DS, Li..., Mol Neurodegener, 1/1/2015
Neurobehavioral aspects, pathophysiology, and management of Tourette's syndrome
Shprecher D, Schrock L, Himle M, Curr Opin Neurol, 1/1/2014
Sustained remission of Parkinson disease associated melanoma with immunotherapy
Shprecher D, Grossmann K, Tward J, Parkinsonism Relat Disord, 1/1/2014
Elucidating the mechanism of tic improvement in Tourette syndrome: a pilot study
Shprecher D, Gannon K, Agarwal N, Shi X, Anderson J, Tremor Other Hyperkinet Mov, 1/1/2014
Temporal Course of the Tourette Syndrome Clinical Triad
Shprecher D, Rubenstein L, Gannon K, Frank S, Kurlan R, Tremor Other Hyperkinet Mov (NY), 1/1/2014
Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson'...
Elm JJ, NINDS NET-PD Investigators, Mov Disord, 1/27/2012
Sensory Trick with Metoclopramide associated Tardive Tremor
Shprecher D, BMJ Case Rep, 1/1/2012
Parkinson disease: the enteric nervous system spills its guts [Letter to the editor]
Shprecher DR, Derkinderen P, Neurology, 1/1/2012
Willingness of Parkinson Disease Patients to Participate in Research Using Internet Based Technology
Shprecher D, Noyes Katia, Biglan Kevin, Wang Dongwen, Dorsey Ray E, Kurlan Roger, Adams Michael Jacob, Telemed J E Health, 1/1/2012
Tourette’s Disorder [Review]
Lyon G, Shprecher D, Coffey B, Kurlan R, Curr Treat Options Neurol, 1/1/2010
Normal pressure hydrocephalus: diagnosis and treatment [Review]
Shprecher D, Schwalb J, Kurlan R, Curr Neurol Neurosci Rep, 1/1/2008
Willingness of Parkinson Disease Patients to Participate in Research Using Internet Based Technology.
Shprecher D, Noyes Katia, Biglan Kevin, Wang Dongwen, Dorsey Ray E, Kurlan Roger, Adams Michael Jacob, Telemed J E Health
Sensory Trick with Metoclopramide associated Tardive Tremor.
Shprecher D, BMJ Case Rep
Join now to see all

Books/Book Chapters

Treating Disruptive Disorders: A Guide to Psychological, Pharmacological, and Combined Therapies.
Chapter: Tourette Syndrome and Other Tic Disorders.
Hayes L, Himle M, Ramanujam K, Shprecher DEditors: Kapalka G.Routledge2015
Uncommon Causes of Movement Disorders.
Chapter: Tics and Tourette syndrome.
Roger Kurlan and David ShprecherEditors: Nestor Galvez-Jiménez and Paul Tuite.Cambridge University Press2011
The Encyclopedia of Movement Disorders.
Chapter: Complex tics.
Shprecher D, Kurlan REditors: Komploti K and Verhagen L.Elsevier2010
The Encyclopedia of Movement Disorders.
Chapter: Simple tics.
Shprecher D, Kurlan REditors: Komploti K and Verhagen L.Elsevier2010
Complextics.
Chapter: The Encyclopedia of Movement Disorders
Shprecher D, Kurlan REditors: Komploti K and Verhagen L.Elsevier
Simple tics.
Chapter: The Encyclopedia of Movement Disorders
Shprecher D, Kurlan REditors: Komploti K and Verhagen L.Elsevier
Tics and Tourette syndrome.
Chapter: Uncommon Causes of Movement Disorders
Roger Kurlan and David ShprecherEditors: Néstor Gálvez-Jiménez and Paul Tuite.Cambridge University Press
Join now to see all

Abstracts/Posters

Visual Hallucinations and Visual Misperceptions in Parkinson's Disease: A Retrospective Chart Review.
Kelsey Juster Switlyk MD, Greg Philips, David Shprecher DO, Edward Zamrini MD, Rodolfo Savica MD PhD, AAN 67th Annual Meeting, 1/18/2015
Amantadine vs rimantadine in Parkinsonian disorders: A retrospective comparative tolerability study.
Saminejad, B., Gannon, K., Zorn, M., Shprecher, D.R, Movement Disorders, 1/1/2015
Colonoscopic screening for enteric nervous system pathology in Parkinson’s disease
D.R. Shprecher, L. Huynh, P. Wall, S. Tripp, K. Boynton, J. Fang, J.B. Leverenz, J. Sonnen, 18th International Congress of Parkinson Disease and Movement Disorders, 1/1/2014
Understanding risk of parkinsonian disorders.
D. Shprecher, J. Bautista, A. Davis, R. Savica, 18th International Congress of Parkinson Disease and Movement Disorders, 1/1/2014
Neuroprotection trials in populations enriched for Parkinson disease risk.
Shprecher DR, OHSU, Northwest Basal Ganglia Coterie, Victoria, British Columbia, Canada, 1/1/2014
Neuropsychiatric Side Effects of Cyclobenzaprine.
Shprecher D, Sloan CT, Sederholm B, Movement Disorders, 1/1/2013
Parkinson Disease Lesion Effect and Melanoma Treatment Response with Ipilimumab and Whole Brain Radiation.
Shprecher D, Grossman K, Tward J, Movement Disorders, 1/1/2013
HD Clinical Research.
Shprecher DR, HDSA Huntington's Disease Education Day, Salt Lake City, UT, 1/1/2012
Planning Clinical Trials in REM sleep behavior disorder.
Shprecher DR, Northwest Basal Ganglia Coterie, OHSU, Seattle, WA, 1/1/2012
21st century neurology: towards preclinical diagnosis of Lewy body disorders.
Shprecher DR, Pacific Northwest Basal Ganglia Coterie (OHSU), Hood River, OR, 1/1/2011
A Clinical and Biomarker Discovery Initiative to Identify Individuals with Premotor Parkinson’s disease.
Shprecher DR, Working Group on Clinical Trials, University of Rochester, 1/1/2009
Copper Deficiency Myelopathy
Shprecher DR, Unusual Diagnostic and Management Problems in Neuromuscular Disease, American Academy of Neurology, Boston, MA, 1/1/2007
Age at remission in patients with Tourette syndrome.
Rubenstein L, Shprecher D, Frank S, Kurlan R, Movement Disorders
Neurodevelopment of Dopamine Systems: Insights into the Pathogenesis of Tourette Syndrome.
Shprecher D, 22nd Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson’s Disease and Other Mov, Salt Lake City, UT
Case Presentation: Copper Deficiency Myelopathy.
Shprecher, D, Unusual Diagnostic and Management Problems in Neuromuscular Disease, American Academy of Neurology, Boston, MA
Neuroimaging to elucidate the nature and mechanism of tic remission in Tourette syndrome using magnetic resonance imaging.
Shprecher, D, Fitts, W, Agarwal, N, Shi, X, Prescott, A, Anderson, J, American Academy of Neurology
Dysphagia as a presenting symptom of progressive supranuclear palsy.
Shprecher D and Evans R, Mov Disord
Identifying potential subjects for Tourette syndrome clinical research.
Shprecher D, Rubenstein L, Wang D, Kurlan R, American Society for Experimental Therapeutics, Arlington, VA
Join now to see all

Lectures

Progress and Hope through Parkinson Disease Research.
Salt Lake City, UT - 1/1/2015
Planning Neuroprotection Trials in Premanifest Lewy body disorders.
Scottsdale, AZ - 1/1/2015
Understanding the Spectrum of Parkinsonian Disorders
University of Utah, Salt Lake City, UT - 1/1/2014
Hope through Parkinson Disease Research.
Logan, UT - 1/1/2014
What does research mean to you?
Salt Lake City, UT - 1/1/2014
Evaluation and Management of Parkinsonian Disorders
University of Utah, Salt Lake City, UT - 1/1/2014
Neuroprevention Trials in Populations at-risk for Parkinson’s: are we there yet?
University of Utah, Salt Lake City, UT - 1/1/2014
Clinical Update on Pediatric Movement Disorders
Primary Children's Medical Center, Salt Lake City, UT - 1/1/2013
Advancing Treatments for Parkinson’s Disease.
St. George, UT - 1/1/2013
Clinical Update on Hyperkinetic Movement Disorders
University of Utah - 1/1/2013
Your Progress Report: What’s new in PD research?
Salt Lake City, UT - 1/1/2013
Clinical Update On Management of Movement Disorders
University of Utah - 1/1/2012
21st Century PD Research: Where are We Headed?
Logan, UT - 1/1/2012
Early Diagnosis and Treatment of Parkinson Disease
University of Utah - 1/1/2010
Avenging Dudley: On the Frontlines of Progressive Supranuclear Palsy Research
University of Utah - 1/1/2010
Neurodevelopment of Dopamine Systems: Insights into the Pathogenesis of Tourette Syndrome
Salt Lake City, UT - 1/1/2008
Delayed Leukoencephalopathy
University of Utah - 1/1/2006
Movement Disorders Emergencies.
Western Intermountain Neurological Organization (WINO) Brainstorm Conference. Park City, UT
REM Sleep Behavior Disorder: The Ultimate Harbinger of Neurodegenerative Disease.
University of Utah
Clinical Update On Management of Movement Disorders.
University of Utah
Avenging Dudley: On the frontlines of progressive supranuclear palsy research.
University of Utah
Early Diagnosis and Treatment of Parkinson Disease.
University of Utah
Near Death Experiences and the Paradox of Consciousness
University of Utah
Delayed Leukoencephalopathy.
University of Utah
Hope through PD Research at the University of Utah.
American Parkinson Disease Association, Ogden, UT
Join now to see all